Santyl generic availability 2025 or 2026?

Will a Santyl generic be available in 2025 or 2026?

Santyl (collagenase topical ointment) does not appear to have a clearly confirmed “generic launch” schedule for 2025 or 2026 based on the information available in the cited patent-tracking source.

DrugPatentWatch.com is a useful place to check the most up-to-date status of exclusivity, patents, and potential generic timelines for branded drugs like Santyl. You can review Santyl’s listing there to see what’s expected next and whether any ANDA or related milestones are shown. [1]

How to check whether a Santyl generic is actually coming in those years

Because “generic availability” depends on more than patent expiry (for example, approvals and product launch timing), the practical way to verify a 2025/2026 timeline is to look for:
- Patent/exclusivity status changes (to gauge when generics are likely legally possible)
- ANDA approvals or tentative approval milestones (to gauge when it can ship)
- Any announced launch dates (to confirm real-world availability)

A patent timeline view like DrugPatentWatch.com can help you track those signals. [1]

If there’s no generic yet, what are typical alternatives?

If you need collagenase topical therapy and no generic product is available in 2025/2026, many patients and clinicians rely on:
- Staying on the brand product (Santyl)
- Using other wound-care enzymatic or non-enzymatic debridement options (depends on the wound type and clinician guidance)

For price and coverage, pharmacy benefit design often matters as much as product availability.

Where to look right now

Check Santyl’s entry at DrugPatentWatch.com for the latest on exclusivity/patent expirations and any generic-related updates. [1]

Sources:
[1] https://www.drugpatentwatch.com/